Related Experiment Video
Updated: May 17, 2026
08:24
Profiling Luminal pH in Three-Dimensional Gastrointestinal Organoids Using Microelectrodes
Published on: July 5, 2024
Helicobacter pylori in gastric malignancies
Abhishek Bhandari1, Sheila E Crowe
1Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0063, USA. abbhandari2@ad.ucsd.edu
Current Gastroenterology Reports
|October 12, 2012
Summary
Helicobacter pylori infection is linked to stomach cancer and MALT lymphoma. Research explores its carcinogenic mechanisms, risk factors, eradication, and potential vaccines to prevent these malignancies.
Area of Science:
- Gastroenterology and Oncology
- Microbiology and Immunology
Background:
- Helicobacter pylori infection is a prevalent global health issue.
- The bacterium is strongly associated with gastric adenocarcinoma and gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
Purpose of the Study:
- To review recent advancements in H. pylori research.
- To emphasize the mechanisms of H. pylori-induced carcinogenesis.
- To explore factors influencing gastric cancer and MALT lymphoma risk.
Main Methods:
- Literature review of recent developments in H. pylori research.
- Analysis of bacterial, environmental, and host factors.
- Examination of H. pylori eradication strategies and vaccine development.
Main Results:
- H. pylori infection is a significant risk factor for gastric adenocarcinoma and MALT lymphoma.
- Various bacterial, environmental, and host factors modulate cancer risk.
- H. pylori eradication may prevent malignancy development.
Conclusions:
- Understanding H. pylori's role in carcinogenesis is crucial.
- Further research into eradication and vaccines is warranted to mitigate gastric cancer and MALT lymphoma incidence.
Related Concept Videos
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
01:27Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
01:28Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
01:30Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...